SynthesisScientific reports2022

Survival benefit with adjuvant chemotherapy in stage III microsatellite-high/deficient mismatch repair colon cancer: a systematic review and meta-analysis.

Gianluca Tomasello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.